Mar 22 |
Aethlon Medical files to sell common stock, warrants
|
Feb 21 |
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
|
Feb 15 |
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call Transcript
|
Feb 15 |
AEMD: Focus on Oncology Studies; In Vitro Binding Study Expected to Advance Clinical Trial Activities
|
Feb 15 |
Aethlon Medical, Inc. (AEMD) Q3 2024 Earnings Call Transcript
|
Feb 14 |
Aethlon Medical GAAP EPS of -$1.37 in-line
|
Feb 14 |
Recap: Aethlon Medical Q3 Earnings
|
Feb 14 |
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
|
Feb 14 |
Earnings Scheduled For February 14, 2024
|
Feb 7 |
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024
|